» Articles » PMID: 37445980

Induction of Hepcidin Expression in the Renal Cortex of Sickle Cell Disease Mice

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jul 14
PMID 37445980
Authors
Affiliations
Soon will be listed here.
Abstract

In patients with sickle cell disease (SCD), chronic hemolysis and frequent blood transfusions cause iron overload and accumulation in the kidneys. The iron deposition is found in the renal cortex and correlates with the severity of hemolysis. In this study, we observed a significant accumulation of iron in the renal cortex of a mouse model of SCD, and assessed the expression of the proteins involved in maintaining renal iron homeostasis. Despite the intracellular iron accumulation, the levels of the transferrin receptor in the kidneys were increased, but the levels of the iron exporter ferroportin were not altered in SCD mice. Ferroportin is regulated by hepcidin, which binds to it and promotes its degradation. We found reduced serum hepcidin levels but increased renal hepcidin production in SCD mice. Furthermore, we observed significant macrophage infiltration and increased expression of intercellular adhesion molecule 1 in the endothelial cells of the kidneys in SCD mice. These observations correlated with elevated levels of proinflammatory cytokines IL-1β and IL-6, which can potentially stimulate hepcidin expression. Taken together, our results demonstrate that in individuals with SCD, a renal inflammation state induces renal hepcidin production that blocks the upregulation of ferroportin levels, resulting in dysregulation of iron homeostasis in the kidney and iron deposition in the renal cortex.

Citing Articles

Evaluation of iron deposition in diabetic kidney disease using the kidney-to-muscle signal intensity ratio on routine MRI T2WI sequences.

Chu J, Guo A, Hu S, Ma Y, Yang F, Xiao W Abdom Radiol (NY). 2025; .

PMID: 39928100 DOI: 10.1007/s00261-025-04827-w.

References
1.
Mohammad G, Matakidou A, Robbins P, Lakhal-Littleton S . The kidney hepcidin/ferroportin axis controls iron reabsorption and determines the magnitude of kidney and systemic iron overload. Kidney Int. 2021; 100(3):559-569. PMC: 8456337. DOI: 10.1016/j.kint.2021.04.034. View

2.
Fuqua B, Lu Y, Frazer D, Darshan D, Wilkins S, Dunn L . Severe Iron Metabolism Defects in Mice With Double Knockout of the Multicopper Ferroxidases Hephaestin and Ceruloplasmin. Cell Mol Gastroenterol Hepatol. 2018; 6(4):405-427. PMC: 6120670. DOI: 10.1016/j.jcmgh.2018.06.006. View

3.
Agoro R, Mura C . Inflammation-induced up-regulation of hepcidin and down-regulation of ferroportin transcription are dependent on macrophage polarization. Blood Cells Mol Dis. 2016; 61:16-25. DOI: 10.1016/j.bcmd.2016.07.006. View

4.
Merle U, Fein E, Gehrke S, Stremmel W, Kulaksiz H . The iron regulatory peptide hepcidin is expressed in the heart and regulated by hypoxia and inflammation. Endocrinology. 2007; 148(6):2663-8. DOI: 10.1210/en.2006-1331. View

5.
Vichinsky E, Kleman K, Embury S, Lubin B . The diagnosis of iron deficiency anemia in sickle cell disease. Blood. 1981; 58(5):963-8. View